$萊佛士醫療 (BSL.SG)$ Executive Chairman buying the shares at 1.18 (53,000) and 1.24 (300,000) on 1 Aug and 2 Aug respectively.

$Grab Holdings (GRAB.US)$ As per Bernstein latest coverage, i think the current price present a good opportunity to get a piece with a limited downside. Can try some buy and sell range or accumulate some and hope for better results.

$萊佛士醫療 (BSL.SG)$ recent company share buy back (incl Director/CEO) indicates that the price is considerably cheap. The last time there are director/CEO buying was at 0.78 where the share prices went higher not too long after. Dividend is 2.8cents round the corner (2.5cents a year before)
Moverover, with Covid-19still here to stay for some time. Profitability should not be an issue.

$Grab Holdings (GRAB.US)$ With institutional buy Temasek and MSCI inclusion, Grab should have a boost till at least 3 March when they release their result. Make it or break it then...

$富途控股 (FUTU.US)$ 抱有希望的